Literature DB >> 18226846

A family history of psychopathology modifies the decrement in cognitive control among patients with HIV/AIDS.

Lance O Bauer1.   

Abstract

The present study was designed to evaluate the effect of HIV/AIDS on cognitive control and to determine if the effect is modified by familial risk for either alcohol or mood disorders. Sixty HIV-1 seropositive and 75 seronegative volunteers were assigned to four subgroups defined by the crossing of a diagnosis of alcohol dependence in the biological father with diagnoses of either major depressive disorder or bipolar disorder in the biological mother. Cognitive control was evaluated during a task in which subjects were asked, on occasion, to inhibit the impulse to respond in the same physical direction as the stimulus and instead respond in the opposite direction. Event related brain potentials and measures of task performance were recorded. The task evoked a negative shift in a late slow potential (SP) as well as an increment in reaction time when cognitive control was challenged. An important finding was an interaction between trial type, HIV/AIDS, and family history: HIV/AIDS and family history each attenuated the negative shift in the SP to such a degree that no further attenuation could be accomplished by the other. The effects of familial risk for alcohol versus mood disorders were equivalent. In conclusion, the absence of change in a late slow potential following a challenge to cognitive control may represent a marker of familial risk for both externalizing and internalizing disorders. The effects of familial risk on this slow potential are sufficiently robust as to attenuate the effects of HIV/AIDS on the probable generators of the response: the anterior cingulate and prefrontal cortex.

Entities:  

Mesh:

Year:  2008        PMID: 18226846      PMCID: PMC2442883          DOI: 10.1016/j.bandc.2007.12.004

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  111 in total

Review 1.  Substance use disorders, externalizing psychopathology, and P300 event-related potential amplitude.

Authors:  William G Iacono; Stephen M Malone; Matt McGue
Journal:  Int J Psychophysiol       Date:  2003-05       Impact factor: 2.997

2.  Visual P300s in long-term abstinent chronic alcoholics.

Authors:  George Fein; Maria Chang
Journal:  Alcohol Clin Exp Res       Date:  2006-12       Impact factor: 3.455

3.  P300 amplitude as an indicator of externalizing in adolescent males.

Authors:  Christopher J Patrick; Edward M Bernat; Stephen M Malone; William G Iacono; Robert F Krueger; Matt McGue
Journal:  Psychophysiology       Date:  2006-01       Impact factor: 4.016

4.  Frontal P300 decrements, childhood conduct disorder, family history, and the prediction of relapse among abstinent cocaine abusers.

Authors:  L O Bauer
Journal:  Drug Alcohol Depend       Date:  1997-01-10       Impact factor: 4.492

5.  Distribution of brain HIV load in AIDS.

Authors:  C A Wiley; V Soontornniyomkij; L Radhakrishnan; E Masliah; J Mellors; S A Hermann; P Dailey; C L Achim
Journal:  Brain Pathol       Date:  1998-04       Impact factor: 6.508

6.  The Edinburgh cohort of HIV-positive injecting drug users at 10 years after infection: a case-control study of the evolution of dementia.

Authors:  G M Goodwin; D O Pretsell; A Chiswick; V Egan; R P Brettle
Journal:  AIDS       Date:  1996-04       Impact factor: 4.177

Review 7.  A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.

Authors:  Daniel M Forton; Joanna M Allsop; I Jane Cox; Gavin Hamilton; Keith Wesnes; Howard C Thomas; Simon D Taylor-Robinson
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

8.  Differential effect of HIV infection and alcoholism on conflict processing, attentional allocation, and perceptual load: evidence from a Stroop Match-to-Sample task.

Authors:  Tilman Schulte; Eva M Mueller-Oehring; Margaret J Rosenbloom; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Biol Psychiatry       Date:  2005-01-01       Impact factor: 13.382

9.  ASPD blunts the effects of HIV and antiretroviral treatment on event-related brain potentials.

Authors:  Lance O Bauer; John D Shanley
Journal:  Neuropsychobiology       Date:  2005-11-24       Impact factor: 2.328

10.  ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy.

Authors:  Linda L Chao; Joselyn A Lindgren; Derek L Flenniken; Michael W Weiner
Journal:  Clin Neurophysiol       Date:  2004-07       Impact factor: 3.708

View more
  5 in total

Review 1.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

2.  Interactive effects of HIV/AIDS, body mass, and substance abuse on the frontal brain: a P300 study.

Authors:  Lance O Bauer
Journal:  Psychiatry Res       Date:  2010-05-23       Impact factor: 3.222

3.  An obese body mass increases the adverse effects of HIV/AIDS on balance and gait.

Authors:  Lance O Bauer; Zhao Wu; Leslie I Wolfson
Journal:  Phys Ther       Date:  2011-04-28

4.  A family history of substance dependence obscures the group differences in brain function associated with HIV-1 and ART.

Authors:  L O Bauer
Journal:  Drug Alcohol Depend       Date:  2012-06-29       Impact factor: 4.492

5.  HIV/AIDS and an overweight body mass are associated with excessive intra-individual variability in response preparation.

Authors:  Lance O Bauer
Journal:  J Neurovirol       Date:  2018-05-17       Impact factor: 2.643

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.